Skip to main content
Livermore
Livermore
ZHEN

Barclays PLC

SEC CIK
0000312069
Latest filing
Aug 14, 2026

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by Barclays PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overviewAll 13F holders of APLSFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of APLS by Barclays PLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−98,327−100.0%Sold outHolders
Q1 202698,327$3.96M<0.1%−89,385−47.6%ReducedHolders
Q4 2025187,712$4.72M<0.1%−81,815−30.4%ReducedHolders
Q3 2025269,527$6.10M<0.1%−4,385−1.6%ReducedHolders
Q2 2025273,912$4.74M<0.1%+82,675+43.2%AddedHolders
Q1 2025191,237$4.18M<0.1%+31,672+19.8%AddedHolders
Q4 2024159,565$5.09M<0.1%−96,332−37.6%ReducedHolders
Q3 2024255,897$7.38M<0.1%+39,019+18.0%AddedHolders
Q2 2024216,878$8.32M<0.1%+191,086+740.9%AddedHolders
Q1 202425,792$1.52M<0.1%−170,599−86.9%ReducedHolders
Q4 2023196,391$11.8M<0.1%−146,498−42.7%ReducedHolders
Q3 2023342,889$13.0M<0.1%+30,659+9.8%AddedHolders
Q2 2023312,230$28.4M<0.1%+70,049+28.9%AddedHolders
Q1 2023242,181$16.0M<0.1%+14,834+6.5%AddedHolders
Q4 2022227,347$11.8M<0.1%+94,198+70.7%AddedHolders
Q3 2022133,149$9.10M<0.1%+109,713+468.1%AddedHolders
Q2 202223,436$1.06M<0.1%−29,168−55.4%ReducedHolders
Q1 202252,604$2.67M<0.1%−92,644−63.8%ReducedHolders
Q4 2021145,248$6.87M<0.1%+112,555+344.3%AddedHolders
Q3 202132,693$1.08M<0.1%−4,426−11.9%ReducedHolders
Q2 202137,119$2.35M<0.1%−54,915−59.7%ReducedHolders
Q1 202192,034$3.95M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.